Objectives The aims of this study were to (1) describe the results of a survey on the clinical features of lymphoma in Australian Border Collies and (2) investigate familial clustering of lymphoma-affected dogs by means of pedigree analyses.
L ymphoma is one of the most common canine cancers, but its aetiology remains largely unknown. Development of lymphoma is assumed to be the result of complex interactions between genetics and environment. Genetic factors may be broadly categorised into germline variants with potential driver mutation function and somatic changes within tumours. Somatic hypermutation, whole chromosomal aberrations, altered gene expression and epigenetic changes have all been documented in dogs with lymphoma. [1] [2] [3] [4] [5] [6] [7] [8] Other factors related to environmental effects have also been implicated, including exposure to herbicides and other chemicals, [9] [10] [11] [12] residing in an industrial area 9, 13, 14 and exposure to strong magnetic fields. 15 There is further evidence for increased risk associated with a history of immune-mediated thrombocytopenia, 16 atopic dermatitis 17 and gammaherpesvirus infections. 18 Breed predisposition indicates a potential genetic component for the risk of developing disease. Previous studies have identified breeds with a consistent increased risk of lymphoma despite different geographic locations, 13, [19] [20] [21] [22] [23] [24] but reported at-risk breeds may also vary between geographic regions. 19, 21, 25 Although this may be explained by breed popularity or environmental factors in different regions, selective breeding based on genetically restricted subpopulations will also contribute.
Our recent study of the demographics of more than 6000 dogs with lymphoma in Australia demonstrated an increased breed risk (odds ratio (OR) = 1.8; 95% confidence interval (CI) 1.6-2.0) in Border Collies compared with the general population. 25 However, in that study pedigree information was not available for individually affected dogs, preventing a more detailed investigation of any potential genetic aetiology. Collection and analysis of pedigree data has the potential to identify modes of inheritance and carriers of disease in a population. Pedigree analysis has been shown to be useful in several disease studies in dogs, including identifying a common ancestor for neuronal ceroid lipofuscinosis in a Japanese population of Border Collies 26 and segregation of a canine hereditary renal cancer syndrome in German Shepherd Dogs. 27 To the best of our knowledge, pedigree analysis of dogs with cancer has never been performed in an Australian setting. The goals of the current survey were to identify lymphoma cases among Australian Border Collies (ABCs) and to collect associated pedigree data. We report the clinical features of lymphoma in these dogs, as well as an analysis of kinship within the affected subpopulation and compare it with unaffected dogs and a broader registered Border Collie pedigree.
Materials and methods
Approval to conduct the general health survey was obtained from the Human Research Ethics Committee at the University of Sydney (Project no. 2016/559). The survey was conducted between June 2016 and December 2017.
An electronic link for a web-based or hardcopy survey was distributed to owners or breeders of ABCs. The study was promoted in the newsletter of the Border Collie Club of NSW Inc., on the University of Sydney's webpage and by direct communications with practising veterinarians in Australia.
The survey was divided into three sections (Supplementary File 1) . The first section of the survey sought contact details of respondents and primary veterinarians, as well as details of the dogs (registered name and number, microchip number, date of birth, sex, neutered status, age when neutered and country of birth). Respondents were asked for permission for the investigators to contact the primary veterinarian for more information. Medical records and pathology results were requested if consent was granted by the respondents. Review of available medical records, and any required amendments to survey data, was performed by a board-certified veterinary oncologist (PB) and oncology resident (KYC).
The second section asked the respondents about the current health status of their dogs, including 'healthy', 'has an illness' or 'deceased', details of illness and cause of death if applicable. Respondents who had dogs with lymphoma were asked additional questions specific to lymphoma, including age at diagnosis, concurrent illness, clinical features, treatment and outcomes, as well as details of known related dogs diagnosed with lymphoma. The final section requested pedigree information on affected dogs. Respondents were invited to give additional comments at the end of the survey.
Dogs included for analysis in the study were purebred Border Collies with an Australian lineage. Dogs were considered purebred if supported by pedigree documentation or identified as such by a veterinarian or the owner if unregistered. Dogs were considered Australian if registered in Australia or had at least one greatgrandparent from an Australian lineage based on pedigree details or were born in Australia. Dogs were excluded if these criteria were not met. Dogs were also excluded if health status was not stated on the survey. Repeated entries were removed. Upon review of available medical records, dogs were excluded if clinical assessment by a veterinarian was inconsistent with the diagnosis of lymphoma.
Statistical analysis
Chi-squared test was used to calculate the sex predisposition to lymphoma. A P-value < 0.05 was considered statistically significant. Pedigree information was obtained from the survey and cross-checked with an extensive pedigree database with over 80,000 dogs collated from collected data and publically available data. Dogs were included in the pedigree analyses if there was complete pedigree information for at least three generations. The program Contribution, Inbreeding, Coancestry (CFC) 28 was used to fetch all generations preceding surveyed dogs available in the database and to calculate inbreeding values. Inbreeding was calculated in CFC using the method by Sargolzaei et al. 29 The number of equivalent complete generations (EqG), a measure of the depth of the pedigree and defined as the sum of the proportion of known ancestors in each generation, was calculated using optiSel (implemented in R). 30, 31 A kinship matrix based on all generations of pedigree information was created using the software packages pedigree and kinship2 (implemented in R). [32] [33] [34] A group of 10 unaffected individuals was selected to compare kinship values to a dam of interest that occurred frequently in the pedigrees of affected dogs. NetView (implemented in R) was used to generate a high-definition relationship network between lymphoma-affected and -unaffected dogs, based on the kinship matrix. [34] [35] [36] NetView clusters based on mutual k-nearest neighbours were created to visualise the relatedness between individuals using pedigree data. 34, 36 A k-value of 11 was used to cluster dogs included in the survey. To focus on the relationship between affected dogs, a cluster analysis and heatmap display based on the kinship matrix of these dogs was generated, using the package gplots and the Manhattan distance algorithm. 37 Pedigree charts were created using the web-based PhenoTips Playground (playground phenotips.org). 38 Inkscape software version 0.92 (Inkscape Software, USA, www. inkscape.org) was used to annotate the pedigree. A heritability estimate for lymphoma was generated using the software package ASReml-R. 39 
Results
A total of 339 responses were received, 246 of which met the inclusion criteria. Of these, 117 (48%) responders were from New South Wales. The others were from Victoria (n = 40; 16%), Queensland (n = 37; 15%), Western Australia (n = 25; 10%), South Australia (n = 12; 5%), Australian Capital Territory (n = 7; 3%), Tasmania (n = 5; 2%), countries other than Australia (n = 2; 1%) and Northern Territory (n = 1; < 1%).
In total, 113 ABCs (46%) were female (23 entire; 83 neutered; 7 unreported) and 133 (54%) were male (36 entire; 91 neutered; 6 unreported). Of these, 138 (56%) were healthy dogs with no history of lymphoma; 51 (21%) were dogs diagnosed with diseases other than lymphoma.
A total of 57 (23%) dogs had been diagnosed with lymphoma. Age of diagnosis was known for 56 dogs, with a mean age of 9.16 (SD AE 3.43) years and a median of 9.7 years (range 2-15 years) ( Figure 1 ). The median age of unaffected dogs was 12 years (range 2-15 years). Of the 57 lymphoma-affected dogs, 34 (60%; 25 neutered; 5 entire; 4 unknown) were female and 23 (40%; 17 neutered; 6 entire) were male. Among those reported, the odds of female dogs developing lymphoma were more than twice those of male dogs (OR = 2.06; 95%CI = 1.13-3.73; P = 0.02).
Medical records from primary veterinarians were available for review for 24 (42%) dogs and amendments were made if applicable. The anatomical form of lymphoma was reported in 51 (89%) dogs. The multicentric form was the most common and found in 43 (84%) dogs. There were 4 (8%) dogs with alimentary, 3 (6%) with cutaneous, and 1 (2%) with an extranodal form. The immunophenotype was available in 19 of 54 (35%) dogs with lymphoma: 16 (84%) were B-cell and 3 (16%) were T-cell; 21 (37%) dogs had the grade of lymphoma recorded, including 18 (86%) with high-grade, 2 (9%) with intermediate and 1 (5%) with low-grade lymphoma. Staging was reported in 34 (60%) dogs. As most dogs did not have complete diagnostic tests for staging, the results were grouped as Stage I, II-IV and suspected V or leukaemia, which were identified in 1 (3%), 25 (73%), and 8 (24%) dogs, respectively.
As for medical histories, 5 dogs had previously had other tumours, including 3 with masses of unknown origin and 1 each with lipoma and ameloblastoma; 9 dogs had a history of infections, including 6 with skin or ear infections and 3 with urinary tract infections. None of the dogs had a history of immune-mediated thrombocytopenia. Of the other illnesses recorded, 16 dogs included 4 with arthritis, 3 with skin allergy, 2 with renal disease and 1 each with liver disease, epilepsy, vestibular disease, laryngeal paralysis, urinary incontinence, pancreatitis and discoid lupus erythematosus.
The questions on treatments for lymphoma were answered by 50 (88%) responders: 13 (26%) dogs did not receive any treatment and 37 (74%) received treatment, including 20 (54%) with chemotherapy, 8 (22%) with prednisolone alone and 6 (16%) with 'other'. Three dogs (8%) had surgery, with two cases of surgery alone and one of surgery and chemotherapy.
At least three generations of pedigree information were available for 103 of the 246 (40%) dogs included in the study; 39 of the 57 (68%) dogs with lymphoma had pedigree information for analysis. Three dogs were born in the USA, but had at least one Australian grandparent or great-grandparent and were therefore included in the analysis.
Between 9 and 17 generations were recovered for lymphoma-affected dogs (2645 dogs in total, including generation 0 dogs) and between 10 and 18 generations for unaffected dogs (3634 dogs in total, including generation 0 dogs). After removing 14 dogs with only one known parent and keeping only unique dogs between both datasets, 3933 dogs remained. With this data, a kinship matrix was created and the lymphoma-affected and -unaffected dogs were subset for analyses and to generate the NetView and heatmap images. In NetView, nodes represent individual dogs and lines (edges) represent relationships between dogs, where proximal nodes with short lines indicate closely related dogs. Two sub-networks of dogs were evident in the NetView analysis, with a spread of affected dogs throughout both subgroups (Figure 2 ). In the first major cluster (Figure 2 (Figures 3, 4) .
Pedigree mapping revealed the direct ancestry of affected dogs. In some cases the animals appeared in the same line or family group. These included two instances of affected dam and daughter, a pair of affected littermates, two instances of affected parental sibling and two instances of affected half-siblings. A subtotal of 28 cases were mapped to one common ancestor, dog-67066 (I-2) (Figure 4) , which was the second most frequently occurring dam in the pedigrees of affected dogs (14 times). Dog-65895 (II-4) from this pedigree was related to 23 cases, predominantly through two heavily used sires that descended from this dog: dog-50624 (IV-2) and dog-50681 (V-1). These two dogs were each related to 14 and 12 cases, respectively (5 cases were shared between these dogs). Dog-50624 (IV-2) appeared in the pedigrees of affected dogs 17 times and 25 times in unaffected dogs. Dog-50681 (V-1) appeared 8 times in both affected and unaffected dogs. A total of 11 (39%) of the 28 affected dogs related to the common dam (dog-67066) were diagnosed at 11 years or older. The remaining 17 dogs were diagnosed under 10 years of age (3.5-9.9 years) In the 4 cases of dogs descended from dog-44286 (VI-2) there was a mean age of diagnosis of 4.5 years (range 3.5-6.1 years) The littermate of this dog, dog-44277 (VI-1) was related to 6 other cases, with a mean age of diagnosis of 8.6 years (range 3.5-15.25 years). Among the 10 ABCs randomly selected from the extensive database to compare kinship values to the common dam in the pedigree, there were 13-15 generations of ancestry available and the average kinship value to the common dam was 0.14 (SD AE 0.03) (Figure 4) . The inbreeding coefficient (F), a value used to describe the relatedness between an individual's parents, was calculated for each dog based on all preceding pedigree data available from the pedigree database containing 80,000 dogs. The mean inbreeding coefficient for the 103 surveyed pedigree dogs was 0.15 (SD AE 0.06, range 0.01-0.32), while for lymphoma-affected and -unaffected dogs, the values were 0.16 (SD AE 0.06, range 0.04-0.27) and 0.15 (SD AE 0.06, range 0.01-0.32), respectively. When frequency distributions of F among lymphoma-affected and -unaffected dogs were examined, they followed a similar pattern ( Figure 5) . Inbreeding values for the two heavily used sires, dog-50624 (IV-2) and dog-50681 (V-1) (Figure 4) , were 0.18 and 0.22, respectively. The most frequently occurring dam (15 times) was the dam of dog-77563 (I-1) and occurred frequently because of its relationship to two affected dogs. This included dog-5596 (F = 0.157), whose grandparent was dog-77563 (I-1) and the fifth most frequently occurring dam (10 times, not shown in pedigree) was both its grandparent and great-grandparent. This dog was not related to the common dam of interest and was not included in the count of 28 related cases. The second affected dog (dog-37478) had a lower F-value of 0.049; however, its dam had an F-value of 0.17 because of cross-breeding of descendants from the fourth most popular dam (11 times). The third most frequently appearing dam (13 times) was the offspring of the suspect dam and was included in the pedigree (dog-65911 (II-2)).
Pedigree mapping assisted in identifying relationships of antecedents for lymphoma-affected dogs. Some notable examples included one dog (F = 0.23; EqG = 11.76) with three half-sibling grandparents, another dog (F = 0.25; EqG = 13.49) whose paternal grandsire, dam and maternal grand-dam's sire were half-siblings and another dog (F = 0.27; EqG = 12.89) whose dam was a half-sibling of the paternal grand-dam (common dam) and also a half-sibling of the paternal grandsire (common sire). Heritability for lymphoma was calculated using the 103 pedigree dogs with their 3831 ancestors and was estimated to be 0.04 (SE AE 0.19). This estimate should be viewed with caution, given the limited numbers of dogs in the lymphomaaffected group relative to the extended pedigree and incomplete disease data, all of which would contribute to the accuracy of this estimate ( Figure 5 ).
Discussion
Based on an exhaustive search of published studies, this is the first breed-specific study describing the clinical features and pedigree analyses for Border Collies affected with lymphoma in Australia. The survey identified the largest group of lymphoma-affected ABCs with accompanying pedigree data that has been reported to date. The analyses performed provided evidence that there is familial clustering in affected ABCs, consistent with conclusions from epidemiological studies that a genetic predisposition for canine lymphoma is present in ABCs. 22, 25 The mean age of diagnosis in this study was 9 years and was comparable to that of previous non-breed-specific studies, which reported a mean range of diagnosis from 6.7 to 8.3 years. 13, 19, 20, 40, 41 The peak age for developing lymphoma in this study was 7-11 years, which is consistent with previous reports. 1, 19, 42 However, there was a very wide range of ages for disease onset and there were a significant proportion of dogs (29%) that were diagnosed between the ages of 1 and 6 years. This earlier onset of lymphoma has also been observed in some other predisposed breeds. For example, Bullmastiffs have been shown to have a substantial number of cases of lymphoma between 4 and 6 years of age in both the UK 19 and Australia. 21 In people, familial risk of non-Hodgkin's lymphoma is not limited to early onset cases, 43 but it is apparent in other haematological malignancies. Cancers diagnosed at an earlier age of onset tend to have a more pronounced hereditary component than late-onset cancers. 44 It may be useful to investigate potential differences in aetiology between age groups of dogs and to identify contributing genetic risk factors.
Female dogs had twice the odds of being reported as affected by lymphoma than male dogs in this study, which was in contrast to previous findings across multiple breeds that females, 25 and particularly intact females, had a decreased risk 21 , although there may be some breed variation for sex predisposition. 25 Furthermore, the common practice of desexing in Australia most likely explains the small number of entire dogs in this study, making interpretation of this information difficult. In people, being female and the use of hormone therapy with oestrogen and/or progestin have been associated with a decreased risk of non-Hodgkin's lymphoma, 45, 46 although another study did not show the same relationship. 47 In total, 84% of ABCs in this study had B-cell lymphoma, which is consistent with previous studies. 1, 20, 40, 41, 48 The most common type of lymphoma reported in this study was multicentric, high-grade B-cell lymphoma, with the most common clinical stages being II-IV. A previous study reported that 66% of all affected dogs had B-cell lymphoma and in some breeds B-cell lymphoma represented more than 80%. 1 The prevalence of different immunophenotypes has not been reported in Border Collies, but 10 of 11 Border Collies included in a previous report were diagnosed with B-cell lymphoma. 1 Immunophenotyping information in this study was only provided by 19 responders, which may be an indicator that there is little motivation to perform the tests if dogs were being treated with palliative prednisolone or that there is lack of awareness of the benefits of performing such tests in general veterinary practice.
A history of having another malignancy or infection was not common in the ABCs in this study. It has been reported that dogs with immune-mediated thrombocytopenia have a 5-fold elevated risk of developing lymphoma, 16 but none of the dogs in the present study had a reported history of this. Most of the treated dogs in the study had been administered chemotherapy or palliative prednisolone and the rest had undergone surgery or other treatments not specified by the respondents. More detailed information on treatment was not requested.
Breed predisposition, 13, [19] [20] [21] [22] [23] [24] 41 ,49,50 a high incidence of specific immunophenotypes in some breeds 1, 13, 51 and familial clustering [52] [53] [54] support a role for a contribution of genetic background to the risk of developing lymphoma. The most commonly reported breeds include Boxers, Bulldogs and Bullmastiffs. 19, 21, 52 Boxers have a significantly higher prevalence of developing the T-cell subtype, compared with a higher prevalence of the B-cell subtype in Cocker Spaniels, Doberman Pinschers, German Shepherd Dogs and Rottweilers. 1, 13, 51 Moreover, increased prevalence of T-cell lymphoma has been demonstrated in genetically related dog breeds, such as 'Spitz' breeds and Asian 'lap' dogs. 1 This suggests that a susceptibility to developing T-cell lymphoma may have arisen prior to breed formation. 1 Affected and unaffected dogs were dispersed throughout the two subgroups identified in the NetView analysis. Hence, the extent of relationships and familial clustering between affected dogs was more closely investigated. Familial clustering for lymphoma has previously been reported in Bullmastiffs, Rottweilers and Otterhounds. [52] [53] [54] Familial clustering in the ABCs of this study was apparent in both the network distribution and cluster analysis. For example, the pedigrees of 14 related (ϕ = 0.17-0.39) lymphoma-affected dogs included 2 frequently used sires. Examining the pedigrees for these sires showed that they were related to 21 cases in total. Mapping of pedigrees also revealed a common female ancestor for 28 cases. It is possible that the most frequently occurring dam contributed to the genetic susceptibility of lymphoma in its descendants; however, it did not account for the other line of descendants from dog-65895 (II-4), which was related to many other cases. Thus, we considered that the common dam (dog-67066 (I-2)) was the origin of a potential genetic risk in this pedigree because it bridged the relationships between both major lines of descendants, which was not seen in the other popular dams. Further studies would be required to confirm the genetic contributions towards disease susceptibility for individuals in this pedigree.
Average inbreeding estimates for affected and unaffected dogs were similar and did not distinguish any direct effect of inbreeding on the occurrence of lymphoma. However, the estimates from this study are much higher than previously reported in ABCs (0.041, n = 20,173; EqG = 7.6) 55 and may reflect lower genetic heterozygosity in this subpopulation of dogs. The identification of frequently used sires in the pedigree of some of these dogs is a common source of increased inbreeding values in purebreds. Further investigation using molecular data would provide more details on the differences of this subpopulation and the effects on lymphoma occurrence. An accurate estimation of heritability was not possible with the data used in this study, given the relatively small sample size, as well as the missing data from the ABC population and lack of known disease status of ancestors. Although familial predisposition may also indicate influences of environmental or infectious factors, these are considered to be unlikely because the majority of dogs in the present study did not share the same environmental exposure.
Similarly, familial predisposition has been demonstrated in people with different subtypes of lymphoma.
56-58 A 1.7-fold increased risk of non-Hodgkin lymphoma was reported for those with a firstdegree relative with the same disease. 56, 57 Moreover, a large cancer registry study has shown that first-degree relatives of diffuse large B-cell lymphoma cases had an almost 10-fold increased risk of developing it. 59 Understanding of the mechanisms in lymphoma predisposition is limited in people. Using techniques such as targeted sequencing 60 or whole exome/genome sequencing, [61] [62] [63] germline variants in 49 genes have been associated with diffuse large B-cell lymphoma. 64 Most of these genes are involved in DNA repair or immune function 60, 64 and are suspected to contribute to the pathogenesis of lymphoma. Similarly, knowledge of germline mutation in dogs is limited. One study of Golden Retrievers in North America identified two shared predisposing loci contributing to a 20% increased risk of developing lymphoma and haemangiosarcoma. 65 The present study demonstrated that breed-specific genetic studies have the potential to clarify genetic risks without the confounding effects of inter-breed diversity.
Study limitations
The current survey avoided potential referral bias from a single institution, but inaccurate information provided by respondents was a potential limitation. Misclassification bias of lymphoma was minimised by the investigators' clinical assessment of medical records and confirmation from respondents when clarification was required. Moreover, the extent of the information on ABC pedigrees was improved by utilising a collated pedigree database. Further limitations of the current study involved potential selection bias towards owners who had experience of dogs with lymphoma, despite our attempts to negate this effect in the survey's design and by advertising it as a general health survey. Breeders with multiple affected dogs would be more motivated to complete the survey. However, many owners of individual ABCs also participated in the study and the relatedness with other affected dogs was only found after examination of pedigree information. Several breeders completed the survey for multiple dogs in their kennels, including unaffected dogs, which may have affected the distribution seen in NetView and likely influenced the estimates for inbreeding and heritability in the population. Analysis of 10 randomly selected dogs revealed moderate kinship to the common dam, which reflected the significant genetic contribution from individuals in this pedigree to the ABC population. The genetic contribution of these individuals to population structure should be incorporated into any future molecular genetic analyses. This may have also contributed to the appearance of two sires multiple times in the pedigrees of both affected and unaffected dogs. It is important to note that dogs that were grouped as unaffected at the time of surveying may have the potential to develop lymphoma later in life. It is plausible that the two sires have passed down a genetic risk to their 21 affected descendants; however, genetic investigations will be needed to pursue the molecular mechanism associated with disease heritability, because there was no simple pattern of segregation of disease in these dogs.
In conclusion, this study provided evidence of a heritable component of canine lymphoma and is the first to report this relationship in the ABC. Results from the survey indicated that a proportion of dogs are susceptible at a young age, but also showed a similar median age of diagnosis with other breeds. Further genetic studies on ABCs should focus on the risk in young dogs and incorporate genotypic data to identify genomic-risk regions. Ultimately, breeding strategies may be modified to reduce the incidence of lymphoma in this breed.
